Probiotic-based treatments for white-nose syndrome using beneficial bacteria are showing promise in field trials, offering hope for welfare improvement in devastated bat populations.
Probiotic treatment for white-nose syndrome represents genuine progress toward addressing one of the most severe wildlife disease welfare crises in modern history. The approach is elegantly aligned with welfare principles — it protects individuals from disease suffering without requiring capture and handling, and it works with natural biological processes rather than against them. Field trial results showing improved survival rates in treated bat populations translate directly to reduced welfare harm from the disease process. The scale of potential benefit is enormous — populations that have experienced 90%+ declines could be stabilized and recover with effective treatment. Developing accessible, deployable treatment systems represents one of the most welfare-impactful conservation technology investments currently available.